Sberbank Investments acquired a 9.99% stake in 812 Capital LLC. The deal closed on August 23. The action passed from the general director of the network of oncology clinics “Evroonko” Khvicha Akubardia. Financial details of the deal were not disclosed, Vedomosti reports.

The Sberbank structure acquired a stake in the network of laboratories of the Medscan holding

The purchase of a stake in the network could amount to 450-500 million rubles, since the value of the entire asset is 4.5 billion rubles, estimated Mikhail Burmistrov, general director of Infoline Analytics.

Eqiva’s consultant, Maria Kolomentseva, assumes that the amount of the transaction was less than 150-200 million rubles. In her opinion, the price of the entire network does not exceed 2 billion rubles, excluding debt obligations.

Euroonco specializes in cancer treatment. Network clinics in Moscow, St. Petersburg, Krasnodar and Samara.

  • In June 2023, SberInvest bought a 49% stake in Medscan Lab LLC, which manages laboratory centers based on multidisciplinary clinics of the Medscan holding company in Moscow, Kursk and Perm. The amount of the settlement was not disclosed. According to analysts, it amounted to about 3 billion rubles.

Author:

Karina Pardaeva

Source: RB

Previous articleRolf’s former head of development Boris Belenky became a shareholder in fintech company CarCraft
Next articleiPhone 15 and iPhone 15 Plus: This is the surprising new color the base models will have
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here